glp-1 drugs depression tied to lower brain inflammation, higher risk GLP-1 Receptor Agonists in Mood

Jadav P., Bahekar R., Shah S

doi: 10.1042/BCJ20170736

Generic phentermine-topiramate ER became available in 2025, which has further reduced costs

Although the SAVOR and EXAMINE studies were delineated to verify cardiovascular safety of two DPP-4i, namely saxagliptin and alogliptin, respectively, both are considered to be the first controlled clinical trials to address the effect of GLP-1 system on CVD

Renal effects of dpp-4 inhibitor sitagliptin or glp-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

Neutrophiltolymphocyte ratio and lymphocytetoCreactive protein ratio in patients with severe coronavirus disease 2019 (COVID19): a metaanalysis